BCM
SGYP

Bayesian Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bayesian Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-40,800
Closed -$75K – 820
2018
Q1 		$75K Buy
+40,800
New +$86.2K 0.02% 538

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Bayesian Capital Management's SGYP Position: Q2 2018 in Review

Bayesian Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2018, closing a stake of 40,800 shares — an estimated $75K sold.

Bayesian Capital Management first reported a position in SGYP in Q1 2018 and held it in 1 quarter. The position peaked at $75K in Q1 2018. 136 funds tracked by Wall St. Rank hold SGYP as of Q2 2018.

  • Bayesian Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2018 after selling out during the quarter.
  • Bayesian Capital Management sold 40,800 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2018, an estimated $75K.
  • Bayesian Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2018 and held it in 1 quarter.
  • Bayesian Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $75K in Q1 2018.
  • 136 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2018.

Based on Bayesian Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.